Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation

Abstract

Multiple Sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system, and the second cause of neurological disability after trauma in young adults in the Western world. The efficacy of disease-modifying treatments (DMTs) in relapsing-remitting (RR) and secondary-progressive (SP) MS is usually surrogated by assessing… (More)
DOI: 10.3389/fnhum.2016.00226

Topics

Cite this paper

@article{Koudriavtseva2016BrainAA, title={Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation}, author={Tatiana Koudriavtseva and Caterina Mainero}, journal={Frontiers in human neuroscience}, year={2016}, volume={10}, pages={226} }